Skip to main
XRAY
XRAY logo

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

DENTSPLY SIRONA (XRAY) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 15%
Buy 15%
Hold 62%
Sell 8%
Strong Sell 0%

Bulls say

Dentsply Sirona demonstrated noteworthy financial growth, with reported sales in Europe increasing by 9.9% and 2.6% on a constant currency basis, indicating strong market performance. The company's Wellspect Healthcare segment was a standout performer, generating $83 million in revenue, representing a 15.6% increase reported and a consistent growth trajectory across all sales regions. Additionally, expectations for improving operating expenses as a percentage of revenue suggest ongoing efficiency gains, positioning Dentsply Sirona favorably for future performance.

Bears say

Dentsply Sirona has revised its sales expectations downwards, now anticipating a constant currency sales decline of 4% to 5%, a notable shift from its previous forecast of 2% to 4%. The company is also facing pressure on its gross margin, projecting a 160 basis point decline in GAAP gross margin in Q3 2025 compared to Q3 2024, alongside a decrease in adjusted EBITDA margin expectations for FY 2025, now estimated to be greater than 18%. Significant challenges are highlighted in the orthodontics segment, specifically a 15% decline attributed to issues related to the Byte business, which is expected to contribute to reduced earnings per share, now modeled at $1.60 down from $1.85.

DENTSPLY SIRONA (XRAY) has been analyzed by 13 analysts, with a consensus rating of Hold. 15% of analysts recommend a Strong Buy, 15% recommend Buy, 62% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DENTSPLY SIRONA and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DENTSPLY SIRONA (XRAY) Forecast

Analysts have given DENTSPLY SIRONA (XRAY) a Hold based on their latest research and market trends.

According to 13 analysts, DENTSPLY SIRONA (XRAY) has a Hold consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DENTSPLY SIRONA (XRAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.